Basic Information
| LncRNA/CircRNA Name | HOXA-AS2 |
| Synonyms | HOXA-AS2, HOXA3as |
| Region | GRCh38_7:27107777-27134302 |
| Ensemble | ENSG00000253552 |
| Refseq | NR_122069 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gallbladder cancer |
| ICD-0-3 | C23.9 |
| Methods | qPCR, Western blot etc. |
| Sample | gallbladder carcinoma tissues, cell lines (NOZ, SGC-996, OCUG, GBC-SD and EHGB-1) |
| Expression Pattern | up-regulated |
| Function Description | Here, we reported that HOXA cluster antisense RNA2 (HOXA-AS2) was upregulated in GBC. |
| Pubmed ID | 28388535 |
| Year | 2017 |
| Title | Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma |
External Links
| Links for HOXA-AS2 | GenBank HGNC NONCODE |
| Links for gallbladder cancer | OMIM COSMIC |